Illumina and Broad Institute Announce Agreement to Co-Develop Genomic Secondary Analysis Tools

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and the Broad Institute of MIT and Harvard today announced they have entered into a collaboration for the co-development of secondary genomic analysis algorithms and software. Top data scientists from both institutions will collaborate to bring together the industry-leading open-source GATK algorithms with the speed and enhanced accuracy of Illumina?s DRAGEN? (Dynamic Read Analysis for GENomics) Bio-IT Platform for commonly used methods,